T-cell Based Immunotherapy for Treatment of Patients With Disseminated Melanoma. A Pilot Study.
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
week 0 to 20
Inge Marie Svane, Professor, MD
Department of Oncology, Copenhagen University Hospital, Herlev, Herlev Ringvej 75, DK-2730 Herlev, Denmark
Denmark: Danish Medicines Agency